A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis

By Collin C.   Ehler E.   Waberzinek G.   Alsindi Z.   Davies P.   Powell K.   Notcutt W.   O'Leary C.   Ratcliffe S.   Nováková I.   Zapletalova O.   Piková J.   Ambler Z.  

Neurological Research, Vol. 32, Iss. 5, 2010-06 ,pp. : 451-459

Maney Publishing

Access to resources Recommend Favorite

A double-blind placebo-controlled multicentre study of sertraline in the acute and continuation treatment of major depression

By Olie J.   Gunn K.   Katz E.  

European Psychiatry, Vol. 12, Iss. 1, 1997-01 ,pp. : 34-41

Elsevier

Access to resources Recommend Favorite

Olanzapine in the Treatment of Developmental Stuttering: A Double-Blind, Placebo-Controlled Trial

By MAGUIRE GERALD   RILEY GLYNDON   FRANKLIN DAVID   MAGUIRE MICHAEL   NGUYEN CHARLES   BROJENI PEDRAM  

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 16, Iss. 2, 2004-01 ,pp. : 63-67

Informa Healthcare

Access to resources Recommend Favorite

Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy

By Sharief M.   Viteri C.   Ben-Menachem E.   Weber M.   Reife R.   Pledger G.   Karim R.  

Epilepsy Research, Vol. 25, Iss. 3, 1996-11 ,pp. : 217-224

Elsevier

Access to resources Recommend Favorite

Botulinum toxin type-A in the prophylactic treatment of medication-overuse headache: a multicenter, double-blind, randomized, placebo-controlled, parallel group study

By Sandrini Giorgio  

The Journal of Headache and Pain, Vol. 12, Iss. 4, 2011-08 ,pp. : 427-433

Springer Publishing Company

Access to resources Recommend Favorite